Endometriosis and Brominated Flame Retardant (ENDOTOX Study)
NCT ID: NCT02651077
Last Updated: 2016-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
76 participants
OBSERVATIONAL
2013-11-30
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EndoxOmics : Exposome, Endometriosis and Fertility
NCT06356753
Exposure to Persistent Organic Pollutants and Severity of Endometriosis in the ComPaRe-Endometriosis Cohort
NCT06973603
Cell Free DNA Quantification in Patients With Endometriosis Followed Witd Medical Assistance to Procreation
NCT05815134
Diagnostic and Prognostic Markers of Endometriosis in Menstrual Blood
NCT06245512
Organic Pollutants in Pelvic Endometriosis
NCT05789407
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case Group
38 women with severe and deep endometriosis, aged 18 to 45 years old and hospitalized at Nantes University Hospital for surgical indication of endometriosis lesions ablation.
No interventions assigned to this group
Control Group
38 women aged 18 to 45 years old without suggestive signs of endometriosis
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Deep endometriosis with or without endometriomas that need surgery (clinical examination, MRI, surgery)
* Accessing to the omental and/or parietal adipose tissue
* Non opposition of the patients for the samples collection and consent for the present study.
Inclusion criterion for the controls :
* Patients without any history of endometriosis and without suggestive symptomatology. Often patients operated for cesarean section.
* Possible access to the adipose tissue of the omentum or abdominal wall
Exclusion criterion for the cases :
* Pregnancy
* Death
Exclusion criterion for controls :
* Pregnancy
* Death
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ONIRIS
INDUSTRY
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephane PLOTEAU, Dr
Role: PRINCIPAL_INVESTIGATOR
Nantes University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nantes University Hospital
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC13_0380
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.